Department of Justice June 2, 2021 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities; Proposed Collection; Comments Requested; Notice of Appeal to the Board of Immigration Appeals From a Decision of a DHS Officer
Document Number: 2021-11527
Type: Notice
Date: 2021-06-02
Agency: Executive Office for Immigration Review, Department of Justice
The Department of Justice (DOJ), Executive Office for Immigration Review (EOIR), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on March 3, 2021, allowing for a 60-day comment period.
Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV
Document Number: 2021-11512
Type: Rule
Date: 2021-06-02
Agency: Drug Enforcement Administration, Department of Justice
This final rule adopts, without change, an interim final rule with request for comments published in the Federal Register on October 6, 2020, placing the substance remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule IV of the Controlled Substances Act. With the issuance of this final rule, DEA maintains remimazolam, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule IV of the Controlled Substances Act.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.